Sarah S. Burns - Concepedia

Author

Sarah S. Burns

The Ohio State University ORCID

Also Known As

Burns, Sarah, Morales, Claudio H., S Ali, S Burns, S. S. Burns, Sarah Burns, Sarah S Burns, Sarah S. Burns

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Nationwide Children's Hospital Harvard University Indiana University – Purdue University Indianapolis Massachusetts General Hospital

About

Sarah S. Burns is an author at The Ohio State University specializing in medicine, systems biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	216
2	Cell Biology	3	3	85
3	Engineering	1	1	30
4	Health Sciences	1	1	34
5	Public Health	1	1	59

Sarah S. Burns

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Obesity-induced inflammation exacerbates clonal hematopoiesis Santhosh Kumar Pasupuleti, Baskar Ramdas, Sarah S. Burns, Journal of Clinical Investigation	2023	91
AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas Matthew L. Bush, Janet L. Oblinger, Victoria J Brendel, Neuro-Oncology	2011	77
FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer Gareth Griffiths, Sarah S. Burns, Simon Noble, BMC Cancer	2009	61
Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting <i>NF2</i> -Deficient Meningioma Growth Sarah S. Burns, Elena M. Akhmametyeva, Janet L. Oblinger, Cancer Research	2012	59
From doctors as patients: a manifesto for tackling persisting symptoms of covid-19 Nisreen A Alwan, Emily Attree, Jennifer Blair, BMJ Preventive MedicineCovid-19.we AimHealthcare ServicesHealth CommunicationGlobal Health Crisis	2020	59
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, PLoS ONE	2021	49
Accessing surgical care for pancreaticoduodenectomy: Patient variation in travel distance and choice to bypass hospitals to reach higher volume centers Adrián Díaz, Sarah S. Burns, Anghela Z. Paredes, Journal of Surgical Oncology	2019	44
Early phase clinical studies of <scp>AR</scp>‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas D. Bradley Welling, Katharine A. Collier, Sarah S. Burns, Laryngoscope Investigative Otolaryngology	2021	36
Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas Janet L. Oblinger, Sarah S. Burns, Elena M. Akhmametyeva, Neuro-Oncology	2016	35

Page 1